Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Chiron to Present at Baird 2005 Growth Stock Conference.


EMERYVILLE, Calif. -- Chiron Corporation Chiron Corporation was a multinational biotechnology firm based in Emeryville, California that was acquired by Novartis International AG on April 20 2006. It had offices and facilities in eighteen countries on five continents.  (Nasdaq:CHIR CHIR Chiricahua National Monument (US National Park Service) ) today announced that it will present at the Baird 2005 Growth Stock Conference in Chicago on Wednesday, May 11, at 2:40 p.m. EDT EDT
abbr.
Eastern Daylight Time


EDT Eastern Daylight Time

EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York

EDT 
. Investors may access a live webcast of the presentation at www.chiron.com/webcast. In order to register and download To receive a file transmitted over a network. In any communications session, "download" means receive, and "upload" means send. The download/upload often implies a big/little scenario, in which data is being downloaded from the "big" server into the "little" user's computer.  any necessary software, please log on 15 minutes early.

About Chiron

Chiron delivers innovative and valuable products to protect human health by advancing pioneering science across the landscape of biotechnology. The company works to deliver on the limitless promise of science and make a positive difference in people's lives. For more information about Chiron, please visit www.chiron.com.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:May 4, 2005
Words:110
Previous Article:Quest Software Reports Earnings for First Quarter 2005; Revenue Grows 25% Year-over-Year to $103.3 Million for the Quarter.
Next Article:Clearly Canadian Updates on Stock Exchange Listings.
Topics:



Related Articles
Chiron Will Not Supply Fluvirin Influenza Virus Vaccine for 2004-2005 Influenza Season.
XOMA and Chiron Announce Preclinical Data Presentations on CHIR-12.12 at American Hematology Conference.
Chiron to Present at Deutsche Bank Healthcare Conference.
Chiron Reports First-Quarter 2005 Pro-Forma Earnings of 4 Cents Per Share, GAAP Loss of 5 Cents Per Share; Chiron Expects 2005 Pro-Forma EPS to Be...
Chiron to Present at Morgan Stanley Global Healthcare Unplugged Conference.
Chiron to Present at Banc of America Healthcare Conference.
Chiron and the Multiple Myeloma Research Consortium Announce Initiation of Phase I Clinical Trial for CHIR-258.
Chiron to Present at Goldman Sachs Global Healthcare Conference.
Chiron Reports Second-Quarter 2005 Adjusted Earnings of $0.08 Per Share, GAAP Earnings of Less Than $0.01 Per Share; 10 Percent Increase in Revenues...
Chiron Announces Merger Agreement with Novartis; Novartis to Acquire Outstanding 58 Percent of Chiron Shares for $45.00 Per Share in Cash; Agreement...

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles